Sign in

You're signed outSign in or to get full access.

Taylor M. Gilden

Chief Financial Officer and Treasurer at LAKE SHORE BANCORP,
Executive

About Taylor M. Gilden

Taylor M. Gilden is Chief Financial Officer and Treasurer of Lake Shore Bancorp, Inc. and Lake Shore Savings Bank; he was appointed CFO in August 2023 after serving briefly as Chief Strategy Officer since June 2023. He is 34 years old as of March 24, 2025, and holds a BS in Accounting and an MS in Finance from American University; prior roles include Senior VP & Controller at FVCbank (Jul 2022–May 2023), VP Finance at BayVanguard Bank (2018–2022), and Deloitte Audit & Assurance (2013–2018) . During his tenure, Company net income was $4.931M in 2024 (vs. $4.820M in 2023) and TSR on a fixed $100 basis improved to 101 from 83, reflecting positive shareholder return alignment with compensation outcomes .

Past Roles

OrganizationRoleYearsStrategic Impact
Lake Shore Bancorp / Lake Shore Savings BankChief Strategy Officer, then Chief Financial Officer & TreasurerJun 2023–Aug 2023; Aug 2023–presentCFO during mutual-to-stock conversion; senior financial oversight
FVCbank (Fairfax, VA)Senior Vice President & ControllerJul 2022–May 2023Financial reporting and controls (banking)
BayVanguard Bank / predecessor 1880 Bank (Baltimore, MD)Vice President of Finance2018–2022Finance leadership (banking)
Deloitte & Touche LLPAudit & Assurance (Financial Services focus)2013–2018Audit experience in financial services

External Roles

No external public company directorships or committee roles were disclosed in Company filings reviewed .

Fixed Compensation

Metric20232024
Base Salary Paid ($)139,423 262,596
Total Cash Compensation (Salary + Bonus + Non-Equity Incentive) ($)185,923 363,121
Total Compensation ($)213,302 433,729

Other Fixed Compensation (2024 detail)

Component (2024)Amount ($)
Employer 401(k) Contribution19,959
ESOP Contributions3,645
Dividends on Unvested Stock Awards2,256
Life Insurance Premiums (> $50k coverage)96
Perquisites— (none disclosed for Gilden in 2024)
All Other Compensation (Total)25,956

Performance Compensation

Annual Incentive (Cash Bonus)

MetricWeightingTargetActualPayout ($)Vesting
Annual Incentive Plan (corporate + individual metrics)Not disclosed10%–37.5% of base salary 38.3% of base salary (2024) 100,525 (2024) Cash; immediate (no vesting)

Compensation Committee establishes corporate and individual metrics annually; specific metric names/weights not disclosed. CEO not involved in decisions regarding his own bonus; Committee presents measures to Board for approval .

Equity Awards (RSUs)

Grant YearUnvested RS at FY End (#)Market Value at 12/31/2024 ($)Vesting ScheduleNotes
2024 grants4,177 57,392 (at $13.74/share) 25% annually starting Apr 23, 2025; over 4 years RS awards vest per schedule; dividends accrue on unvested RS

Stock Options

StatusDetails
None outstanding for GildenNo options granted in 2024 or 2023; no exercisable/unexercisable options listed for Gilden

Equity Ownership & Alignment

Ownership ItemAmount
Total Beneficial Ownership (shares)9,047 (as of Mar 24, 2025)
Direct/IRA Holdings1,862 shares in IRA
ESOP Allocated265 shares (sole voting, no investment power)
Unvested Restricted Stock included in beneficial ownership6,920 shares (sole voting, no investment power)
Ownership as % of Shares Outstanding<1% (asterisk in proxy table)
Anti-hedging / Anti-pledgingCompany policy prohibits hedging and pledging Company stock

Note: Unvested RS count differs by table timing—beneficial ownership at March 24, 2025 includes 6,920 unvested RS , while outstanding RS at FY-end shows 4,177 unvested at Dec 31, 2024 .

Employment Terms

TermDetail
Agreement dateEmployment agreement effective March 11, 2025
RoleChief Financial Officer and Treasurer
Initial term & expirationTerm ends December 16, 2027; thereafter annual extensions to maintain a 3-year rolling term, subject to annual performance review/Board approval at least 90 days before anniversary
CIC term extensionIf a change in control occurs, agreement term automatically renews for ≥36 months from CIC effective date
Base salary (agreement/current)Agreement base salary $265,000; current base salary $265,000
Annual bonus eligibilityPerformance-based cash bonus per Annual Incentive Plan
Long-term incentive eligibilityEligible at Compensation Committee’s discretion
Severance (without cause or for good reason)Lump sum: Accrued Benefits + 1× base salary + average annual incentive (last 3 fiscal years); plus 12 months life/medical/dental continuation (cash lump sum equivalent)
Change-in-control severanceLump sum: Accrued Benefits + 3× (base salary + average annual cash bonus); plus 36 months life/medical/dental continuation; excise tax gross-up for 280G/4999
Trigger mechanicsDouble-trigger (termination without cause or for good reason required); applies to terminations within 3 months before or 12 months after CIC
Restrictive covenantsNon-compete and non-solicit for 1 year post-termination (other than following CIC)
ClawbackNot specifically disclosed in proxy; Company has Code of Conduct and Insider Trading Policy

Investment Implications

  • Pay-for-performance alignment: 2024 cash incentive paid at 38.3% of base salary vs. a 10%–37.5% target range suggests above-target performance outcomes; RSU grants provide multi-year alignment via four-year vesting starting April 23, 2025 .
  • Retention and change-in-control economics: Rolling three-year term and severance of 1× salary+bonus (12 months benefits) mitigate voluntary turnover risk; CIC economics of 3× salary+bonus with 36 months benefits and an excise tax gross-up are shareholder-unfriendly and elevate deal-related costs (red flag) .
  • Insider selling pressure: RSU tranches vest annually beginning April 23, potentially increasing tradable shares at set intervals; while hedging/pledging is prohibited, vest events may correspond with open-window transactions and should be monitored for Form 4 activity and liquidity impact .
  • Ownership alignment: Beneficial ownership is modest (<1% of outstanding) with RS exposure (6,920 unvested RS at Mar 24, 2025), offering alignment but limited downside co-investment relative to float; ESOP and dividend accruals further link compensation to equity performance .
  • Execution track record and governance: Tenure spans the Company’s 2025 conversion and rechartering events (as signatory on multiple SEC filings), with SOX certifications evidencing internal control responsibility; Section 16(a) filings were timely and insider loans were ordinary-course, reducing governance risk signals .